Impact News +++ PDD Holdings Inc. Sponsored ADR (PDD) Q2 Earnings and Revenues Top Estimates (Zacks) +++ PDD HOLDINGS Aktie -4,09%

TERUMO Aktie

>TERUMO Aktienkurs

15.3 EUR -5.0% (Tradegate)

Ask: 15.3 EUR / 326 Stück

Bid: 15.2 EUR / 334 Stück

Tagesumsatz: 190 Stück

Realtime Kurs von 8 bis 22 Uhr!

TERUMO Aktie über LYNX handeln

Intraday

1 Jahr

>TERUMO Performance

1 Woche: -0,6%

1 Monat: +20,1%

3 Monate: -3,6%

6 Monate: -6,1%

1 Jahr: -3,0%

laufendes Jahr: -18,3%

>TERUMO Aktie

Name:

TERUMO CORP.

Land:

Japan

Sektor:

Gesundheit

ISIN/ Wkn:

JP3546800008 / 867003

Symbol/ Ticker:

TUO (Frankfurt)

Kürzel:

FRA:TUO, ETR:TUO, TUO:GR

Index:

Nikkei225

Webseite:

https://www.terumo.co.jp/

Profil:

Terumo Corporation, a leading global medical devic..
>Volltext..

Marktkapitalisierung:

23272.55 Mio. EUR

Unternehmenswert:

23071.6 Mio. EUR

Umsatz:

6147.13 Mio. EUR

EBITDA:

1615.19 Mio. EUR

Nettogewinn:

739.89 Mio. EUR

Gewinn je Aktie:

0.5 EUR

Schulden:

1005.95 Mio. EUR

Liquide Mittel:

1209.91 Mio. EUR

Operativer Cashflow:

1230.33 Mio. EUR

Bargeldquote:

0.75

Umsatzwachstum:

9.27%

Gewinnwachstum:

7.79%

Dividende je Aktie:

0.16 EUR

Dividendenrendite:

0.95%

Dividendenschätzung:

1.1%

Div. Historie:

28.03.25 - 0.0801086€
27.09.24 - 0.081406005€

>weitere anzeigen...

Insiderhandel:

Suchwörter:

TERUMO

Letzte Datenerhebung:

25.08.25

>TERUMO Kennzahlen

Aktien/ Unternehmen:

Aktien: 1474.95 Mio. St.

Frei handelbar: 85.04%

Leerverk. Aktien: -

Rückkaufquote: 0.76%

Mitarbeiter: 30689

Umsatz/Mitarb.: 0.19 Mio. EUR

Analysten:

Analystenrating: Buy

Kursziel: 20.86%

Bewertung:

KGV: 31.74

KGV lG: 27.33

KUV: 3.87

KBV: 2.89

PEG-Ratio: 4.78

EV/EBITDA: 14.28

Rentabilität:

Bruttomarge: 54.78%

Gewinnmarge: 12.04%

Operative Marge: 18.03%

Managementeffizenz:

Gesamtkaprendite: 6.81%

Eigenkaprendite: 8.96%

>TERUMO Peer Group

Es sind 53 Aktien bekannt.

>TERUMO Chart & Kurs - Tradegate

>TERUMO News

25.08.25 - 10:54	Japan′s Terumo to Buy British Firm for Organ Transplant Biz (Nippon)
	Tokyo, Aug. 25 (Jiji Press)--Japanese medical equipment maker Terumo Corp. said Monday that it will fully acquire OrganOx Ltd., a British maker of equipment to preserve organs for transplantation, for 1.5 billion dollars. The acquisition will allow Terumo to make a full-fledged entry into the organ transplantation market, which is forecast to grow. Set up in 2008 as a spinoff from the Uni......

25.08.25 - 10:30	Terumo to buy OrganOx for $1.5bn to enter organ transplant market (Nikkei)
	Um den gesamten Artikel unter asia.nikkei.com zu lesen, klicken Sie bitte auf die Überschrift...

25.08.25 - 07:57	Terumo buys OrganOx in $1.5B deal (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

25.08.25 - 03:48	Terumo Corp. To Acquire OrganOx Limited In $1.5 Bln Deal (AFX)
	TOKYO (dpa-AFX) - Terumo Corp. (TRUMF) has agreed to acquire all outstanding shares of OrganOx Limited, a company specializing in organ preservation devices. The total transaction value is approxi......

25.08.25 - 02:30	Terumo to Buy UK Organ Tech Provider OrganOx for $1.5 Billion (Bloomberg)
	Terumo Corp. has agreed to buy UK-based organ medical tech company OrganOx Ltd. in a deal valued at around $1.5 billion, seeking entry into the organ transplant field....

14.07.25 - 15:03	Terumo Neuro Unveils New SOFIA™ 88 Catheter Data Demonstrating Strong Performance Compared to Other Super-Bore Catheters (PR Newswire)
	Real-World U.S. Physician Preference Data1 Demonstrates the SOFIA™ 88 Catheter's Trackability, Atraumatic Design, and Overall Performance in Stroke Procedures NASHVILLE, Tenn., July 14, 2025 /PRNewswire/ -- Terumo Neuro, a global leader in neurovascular innovation and a wholly owned......

09.07.25 - 15:03	Terumo Health Outcomes Announces Distribution Agreement for Caretaker Medical′s VitalStream® Non-Invasive Hemodynamic Monitoring (PR Newswire)
	– VitalStream wearable delivers real-time, beat-by-beat insights to help clinicians detect cardiovascular changes earlier and respond faster – SOMERSET, N.J., July 9, 2025 /PRNewswire/ -- Terumo Health Outcomes (THO), a division of Terumo Interventional Systems (TIS), today announced a......

17.06.25 - 09:06	MedHub-AI and Terumo partner to market AI-based FFR in Japan (PR Newswire)
	TEL AVIV, Israel, June 17, 2025 /PRNewswire/ -- MedHub-AI, pioneer of AI-based FFR "AutocathFFR" software, today announced a distribution agreement with Terumo Corporation to bring AutocathFFR®, its groundbreaking AI-powered Software as a Medical Device (SaMD), to the Japanese market.......

02.06.25 - 09:03	Expanding a Stroke Legacy: Terumo Neuro Announces EMEA Commercial Availability of the SOFIA™ Flow 88 Neurovascular Aspiration Catheter (PR Newswire)
	Terumo Neuro's SOFIA ™ Catheter Line is Backed By 10 Years of Proven Clinical Performance1-9 and Innovation – The New SOFIA™ Flow 88 Offers Reliable Trackability, Proximal Stability and Vessel-Friendly Flexibility PARIS, June 2, 2025 /PRNewswire/ -- Terumo Neuro, a global leader in......

27.05.25 - 19:42	Terumo Interventional Systems Announces Commercial Availability of Its ROADSAVER™ Carotid Stent System (PR Newswire)
	– Innovative, dual-layer micromesh, closed-cell stent with the flexibility of an open-cell stent for maximizing clinical outcomes in carotid artery stenting procedures – SOMERSET, N.J., May 27, 2025 /PRNewswire/ -- Terumo Interventional Systems (TIS), a division of Terumo Corporation, is......

14.05.25 - 15:24	Terumo GAAP EPS of Yen 78.99, revenue of Yen 1.04T (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

16.04.25 - 21:01	Terumo Blood and Cell Technologies Names Patrick Daly as Chief Business Officer (PR Newswire)
	Daly, a 30-year veteran of the healthcare industry, is the latest leadership addition to help Terumo BCT unite business areas and fuel enterprise growth LAKEWOOD, Colo., April 16, 2025 /PRNewswire/ -- Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company, today......

16.04.25 - 19:15	Terumo Health Outcomes Now Offers FDA-Cleared Medis QFR® 3.0 Software for Coronary Physiology Assessment in the US (PR Newswire)
	– Innovative AI software supports hospital adoption of advanced tools to improve cath lab workflow and patient comfort – SOMERSET, N.J., April 16, 2025 /PRNewswire/ -- Terumo Health Outcomes (THO), a division of Terumo Interventional Systems (TIS), today announced that Medis QFR 3.0, an......

27.02.25 - 14:03	Neuron7 Delivers Resolution Pathways, Transforming Service Delivery with Fast, Accurate Agentic AI Technology That Raises the Standard for Service Excellence (PR Newswire)
	Leading Brands like Daktronics, KARL STORZ, Keysight Technologies and Terumo BCT to Deploy Game-Changing Solution that Simplifies Complex Services Dynamic Domain-Specific AI Takes Information from Any Source to Provide Intuitive Turn-by-Turn Steps to Resolve Critical Issues SAN JOSE,......

13.02.25 - 15:51	Terumo GAAP EPS of ¥66.51, revenue of ¥772.2B (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

07.11.24 - 17:36	Terumo reports 1H results (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

15.10.24 - 19:13	NAMSA and TERUMO Announce Strategic Outsourcing Partnership (Business Wire)
	Um den gesamten Artikel unter morningstar.com zu lesen, klicken Sie bitte auf die Überschrift...

01.10.24 - 18:13	Terumo Neuro (Formerly MicroVention) to Host Grand Opening Ceremony for Newly Expanded Global Headquarters and Innovation Center in Aliso Viejo (Business Wire)
	Um den gesamten Artikel unter morningstar.com zu lesen, klicken Sie bitte auf die Überschrift...

20.09.24 - 19:33	Are You Looking for a Top Momentum Pick? Why Terumo Corp. (TRUMY) is a Great Choice (Zacks)
	Does Terumo Corp. (TRUMY) have what it takes to be a top stock pick for momentum investors? Let's find out....

05.09.24 - 19:33	What Makes Terumo (TRUMY) a New Buy Stock (Zacks)
	Terumo (TRUMY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy)....

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Im strengen Sinne des Wortes hat es nie eine wirkliche Demokratie gegeben und wird es niemals geben. - Jean-Jacques Rousseau

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram